This is a routine tax-withholding sale tied to equity vesting, not a discretionary insider sale. No bearish signal. Monitor for any subsequent Form 4 filings to confirm the sale was executed, but no trading action is warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 11 $6.16entry
- T+1 · 2mo ago +5.52%α +5.97% · $6.50
- T+5 · 2mo ago +2.27%α +2.49% · $6.30
- T+20 · 6w ago −6.33%α −8.20% · $5.77
- T+46 · todayOpen
- T+60 · in 20d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Charles Divita, a Director and Officer of Teladoc Health, filed a Form 144 notice of intent to sell 17,805 shares of common stock, with an estimated aggregate market value of approximately $108,684. The shares were acquired on September 10, 2026, through restricted stock vesting as compensation. The filing is a routine notice of intent to sell shares to cover tax obligations from equity vesting, and does not signal a change in the insider's view of the company's prospects.
Key Facts
- Director and Officer Charles Divita filed a Form 144 to sell 17,805 shares of common stock.
- The estimated aggregate market value of the proposed sale is approximately $108,683.50.
- The shares were acquired on September 10, 2026, via restricted stock vesting as compensation.
- The filing notes the sale is to cover a tax obligation from the settlement of a vested equity award.
- The filing is a routine advance notice of intent to sell, not a report of a completed transaction.
Financial Impact
Proposed sale of 17,805 shares valued at approximately $108,684, representing a small fraction of the company's $1.1B market cap.
Risk Factors
- Insider selling ahead of earnings could be misinterpreted as a negative signal by the market.
- The sale may not be executed; the filing only signals intent.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006894 |
| Document: 0001959173-26-006894-index.html | 0001959173-26-006894 |
| Document: 0001959173-26-006894.txt | 0001959173-26-006894 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Viewing Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers